Cargando…
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
ABSTRACT: The sodium-dependent glucose transporters 2 (SGLT2) plays important role in renal reabsorption of urinal glucose back to plasma for maintaining glucose homeostasis. The approval of SGLT2 inhibitors for treatment of type 2 diabetes highlights the SGLT2 as a feasible and promising drug targe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328422/ https://www.ncbi.nlm.nih.gov/pubmed/30387082 http://dx.doi.org/10.1007/s13659-018-0188-4 |
_version_ | 1783386636995788800 |
---|---|
author | Lu, Yan-Ting Ma, Xiu-Li Xu, Yu-Hui Hu, Jing Wang, Fang Qin, Wan-Ying Xiong, Wen-Yong |
author_facet | Lu, Yan-Ting Ma, Xiu-Li Xu, Yu-Hui Hu, Jing Wang, Fang Qin, Wan-Ying Xiong, Wen-Yong |
author_sort | Lu, Yan-Ting |
collection | PubMed |
description | ABSTRACT: The sodium-dependent glucose transporters 2 (SGLT2) plays important role in renal reabsorption of urinal glucose back to plasma for maintaining glucose homeostasis. The approval of SGLT2 inhibitors for treatment of type 2 diabetes highlights the SGLT2 as a feasible and promising drug target in recent years. Current methods for screening SGLT2 inhibitors are complex, expensive and labor intensive. Particularly, these methods cannot directly measure nonradioactive glucose uptake in endogenous SGLT2-expressing kidney cells. In present work, human kidney cells, HK-2, was incubated with a fluorescent d-glucose derivant 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-d-glucose (2-NBDG) and the fluorescent intensity of 2-NBDG was employed to measure the amount of glucose uptake into the cells. By optimizing the passages of HK-2 cells, 2-NBDG concentration and incubation time, and by measuring glucose uptake treated by Dapagliflozin, a clinical drug of SGLT2 inhibitors, we successfully developed a new assay for measuring glucose uptake through SGLT2. The nonradioactive microplate and microscope-based high-throughput screening assay for measuring glucose can be a new method for screening of SGLT2 inhibitors and implied for other cell assays for glucose measurement extensively. GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13659-018-0188-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6328422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-63284222019-01-25 A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells Lu, Yan-Ting Ma, Xiu-Li Xu, Yu-Hui Hu, Jing Wang, Fang Qin, Wan-Ying Xiong, Wen-Yong Nat Prod Bioprospect Original Article ABSTRACT: The sodium-dependent glucose transporters 2 (SGLT2) plays important role in renal reabsorption of urinal glucose back to plasma for maintaining glucose homeostasis. The approval of SGLT2 inhibitors for treatment of type 2 diabetes highlights the SGLT2 as a feasible and promising drug target in recent years. Current methods for screening SGLT2 inhibitors are complex, expensive and labor intensive. Particularly, these methods cannot directly measure nonradioactive glucose uptake in endogenous SGLT2-expressing kidney cells. In present work, human kidney cells, HK-2, was incubated with a fluorescent d-glucose derivant 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-d-glucose (2-NBDG) and the fluorescent intensity of 2-NBDG was employed to measure the amount of glucose uptake into the cells. By optimizing the passages of HK-2 cells, 2-NBDG concentration and incubation time, and by measuring glucose uptake treated by Dapagliflozin, a clinical drug of SGLT2 inhibitors, we successfully developed a new assay for measuring glucose uptake through SGLT2. The nonradioactive microplate and microscope-based high-throughput screening assay for measuring glucose can be a new method for screening of SGLT2 inhibitors and implied for other cell assays for glucose measurement extensively. GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13659-018-0188-4) contains supplementary material, which is available to authorized users. Springer Singapore 2018-11-01 /pmc/articles/PMC6328422/ /pubmed/30387082 http://dx.doi.org/10.1007/s13659-018-0188-4 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Lu, Yan-Ting Ma, Xiu-Li Xu, Yu-Hui Hu, Jing Wang, Fang Qin, Wan-Ying Xiong, Wen-Yong A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells |
title | A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells |
title_full | A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells |
title_fullStr | A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells |
title_full_unstemmed | A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells |
title_short | A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells |
title_sort | fluorescent glucose transport assay for screening sglt2 inhibitors in endogenous sglt2-expressing hk-2 cells |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328422/ https://www.ncbi.nlm.nih.gov/pubmed/30387082 http://dx.doi.org/10.1007/s13659-018-0188-4 |
work_keys_str_mv | AT luyanting afluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT maxiuli afluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT xuyuhui afluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT hujing afluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT wangfang afluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT qinwanying afluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT xiongwenyong afluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT luyanting fluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT maxiuli fluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT xuyuhui fluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT hujing fluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT wangfang fluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT qinwanying fluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells AT xiongwenyong fluorescentglucosetransportassayforscreeningsglt2inhibitorsinendogenoussglt2expressinghk2cells |